| Literature DB >> 34960637 |
Wen-Lin Su1,2, Chih-Pei Lin2,3, Hui-Ching Huang3, Yao-Kuang Wu1,2, Mei-Chen Yang1,2, Sheg-Kang Chiu2,4,5, Ming-Yieh Peng4,5, Ming-Chin Chan5, You-Chen Chao2,6.
Abstract
To overcome the ongoing coronavirus disease 2019 (COVID-19) pandemic, transmission routes, such as healthcare worker infection, must be effectively prevented. Ultraviolet C (UVC) (254 nm) has recently been demonstrated to prevent environmental contamination by infected patients; however, studies on its application in contaminated hospital settings are limited. Herein, we explored the clinical application of UVC and determined its optimal dose. Environmental samples (n = 267) collected in 2021 were analyzed by a reverse transcription-polymerase chain reaction and subjected to UVC irradiation for different durations (minutes). We found that washbasins had a high contamination rate (45.5%). SARS-CoV-2 was inactivated after 15 min (estimated dose: 126 mJ/cm2) of UVC irradiation, and the contamination decreased from 41.7% before irradiation to 16.7%, 8.3%, and 0% after 5, 10, and 15 min of irradiation, respectively (p = 0.005). However, SARS-CoV-2 was still detected in washbasins after irradiation for 20 min but not after 30 min (252 mJ/cm2). Thus, 15 min of 254-nm UVC irradiation was effective in cleaning plastic, steel, and wood surfaces in the isolation ward. For silicon items, such as washbasins, 30 min was suggested; however, further studies using hospital environmental samples are needed to confirm the effective UVC inactivation of SARS-CoV-2.Entities:
Keywords: 254 nm Ultraviolet C; COVID-19; RT-PCR; SARS-CoV-2; environmental sampling
Mesh:
Year: 2021 PMID: 34960637 PMCID: PMC8706350 DOI: 10.3390/v13122367
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Detection of SARS-CoV-2 and gene contamination in different hospital environments (N = 267).
| SARS-CoV-2 RT-PCR | Ward | ICU | Buffer Area |
|
|---|---|---|---|---|
| Patient CtV, mean ± SE | 20.7 ± 0.5 | 22.9 ± 0.6 | NA | 0.004 * |
| Overall contamination rate, | 16 (15.7) | 3 (2.6) | 0 | <0.001 * |
| human | 44 (43.1) | 27 (23.5) | 8 (16.0) | <0.001 * |
| CtV, mean ± SE | 33.3 ± 0.4 | 32.4 ± 0.8 | 33.5 ± 1.2 | 0.430 |
| | 9 (8.8) | 3 (2.6) | 0 | 0.021 * |
| CtV, mean ± SE | 31.8 ± 0.7 | 36.4 ± 2.1 | NA | 0.02 * |
| | 16 (15.7) | 2 (1.7) | 0 | <0.001 * |
| CtV, mean ± SE | 31.7 ± 0.6 | 31.9 ± 0.7 | NA | 0.930 |
| | 7 (6.9) | 3 (2.6) | 0 | 0.078 |
| CtV, mean ± SE | 31.0 ± 0.4 | 32.3 ± 0.4 | NA | 0.128 |
| Contamination Rate in Different Areas | ||||
| Common area, | 8/57 (14.0) | 1/70 (1.4) | NA | 0.011 * |
| human | 20/57 (35.1) | 11/70 (15.7) | NA | 0.011 * |
| CtV, mean ± SE | 33.5 ± 0.7 | 32.9 ± 1.3 | NA | 0.688 |
| | 4/57 (7.0) | 1/70 (1.4) | NA | 0.173 |
| CtV, mean ± SE | 32.4 ± 0.9 | 33.2 | NA | 0.716 |
| | 8/57 (14) | 1/70 (1.4) | NA | 0.011 * |
| CtV, mean ± SE | 31.5 ± 0.7 | 31.1 | NA | 0.861 |
| | 3/57 (5.3) | 1/70 (1.4) | NA | 0.218 |
| CtV, mean ± SE | 31.0 ± 0.4 | 32.6 | NA | 0.192 |
| Exclusive ward or ICU, | 8/45 (17.8) | 2/45 (4.4) | NA | 0.045 * |
| human | 24/45 (53.3) | 16/45 (35.6) | NA | 0.09 |
| CtV, mean ± SE | 33.2 ± 0.5 | 32.1 ± 1.0 | NA | 0.301 |
| | 5/45 (11.1) | 2/45 (4.4) | NA | 0.434 |
| CtV, mean ± SE | 31.4 ± 1.1 | 38.0 ± 2.4 | NA | 0.03 * |
| | 8/45 (17.8) | 1/45 (2.2) | NA | 0.03 * |
| CtV, mean ± SE | 31.8 ± 1.0 | 32.6 | NA | 0.818 |
| | 4 (8.9) | 2 (4.4) | NA | 0.398 |
| CtV, mean ± SE | 31.0 ± 0.8 | 32.1 ± 0.7 | NA | 0.349 |
CtV, cycle threshold value; SE, standard error; NA, not applicable. The categorical variables are presented as n (%), n: presented as the number of positive results of environmental sampling, (%): presented as the percentage of positive rate. The continuous variables are presented as mean ± SE; a the human RNAse P gene was detected as a nucleic acid extraction procedural control and secondary negative control. (* p < 0.05).
Figure 1Illustration of COVID-19 isolation wards (a) and ICUs (b) indicating the sampling areas. The contamination rate of each area is as follows: Common area: ① IV stand and IV pump (rate = 0/11, 0%); ② bed rail (rate = 4/52, 7.7%); ③ mattress (rate = 0/11, 0%); ④ wall equipment: call bell, oxygen flowmeter, light switch (rate = 0/17, 0%); ⑤ bedside table (rate = 3/25, 12%) ⑥ toilet: toilet seat and flush button (rate = 2/11, 18.2%); ⑦ buffer area (rate = 0/50, 0%); Exclusive ward: ⑧ kettle (rate = 2/12, 16.7%); ⑨ door handle (rate = 0/12, 0%); ⑩ washbasin including toothbrush and mouth cup (rate = 5/11, 45.5%) ⑪ windowsill (rate = 1/5, 20%); ⑫ wardrobe (rate = 0/5, 0%); Exclusive ICU: ⑬ ventilator (rate = 0/11, 0%); ⑭ monitor (rate = 0/11, 0%); ⑮ suction switch (rate = 1/11, 9.1%); and ⑯ EKG lead (rate = 1/12, 8.3%). COVID-19, coronavirus disease-19; ICU: intensive care unit.
Dosage effect of 254-nm UVC radiation at various irradiation periods.
| Control | Irradiation for 5 min | Irradiation for 10 min | Irradiation for 15 min |
| |
|---|---|---|---|---|---|
| Positivity rate, | 5 (42) | 3 (25) | 1 (8) | 0 (0) | 0.045 a |
| human | 7 (58) | 3 (25) | 2 (17) | 2 (17) | 0.077 b |
| CtV, mean ± SE | 32.5 ± 0.9 | 32.0 ± 0.2 | 32.4 ± 1.2 | 33.7 ± 1.5 | 0.837 |
| 3 (25) | 0 (0) | 1 (8) | 0 (0) | 0.088 c | |
| CtV, mean ± SE | 30.4 ± 1.1 | NA | 34.8 | NA | 0.188 |
| 5 (42) | 3 (25) | 1 (8) | 0 (0) | 0.045 d | |
| CtV, mean ± SE | 30.2 ± 0.9 | 33.8 ± 0.8 | 33.1 | NA | 0.071 |
| 3 (25) | 1 (8) | 1 (8) | 0 (0) | 0.237 e | |
| CtV, mean ± SE | 30.3 ± 0.6 | 31.4 | 35.3 | NA | 0.105 |
Patient’s nasal swabs SARS-CoV-2 RT-PCR CtV was 13. CtV, cycle threshold value; SE, standard error; NA, not applicable. The categorical variables are presented as n (%), n: presented as the number of positive results of environmental sampling, (%): presented as the percentage of positive rate. The continuous variables are presented as mean ± SE. a p = 0.005 significance for linear trend, dose effect; b p = 0.025 significance for linear trend, dose effect; c p = 0.064; d p = 0.005 significance for linear trend, dose effect; e p = 0.06.